Skip to main content
. 2021 Apr 15;8:638420. doi: 10.3389/fcvm.2021.638420

Table 5.

Early outcomes for the total cohort and each group before using the matching weight method.

Overall HAR TAR+FET ABO P-value
Characteristic (n = 633) (n = 122) (n = 431) (n = 80)
Early mortality (%) 32 (5.1) 9 (7.4) 19 (4.4) 4 (5.0) 0.418
Stroke (%) 16 (2.5) 2 (1.6) 13 (3.0) 1 (1.2) 0.512
Paraplegia (%) 16 (2.5) 4 (3.3) 12 (2.8) 0 (0.0) 0.291
CRRT (%) 43 (6.8) 11 (9.0) 27 (6.3) 5 (6.2) 0.554
Re-exploration for bleeding (%) 24 (3.8) 5 (4.1) 15 (3.5) 4 (5.0) 0.792
Tracheotomy (%) 20 (3.2) 2 (1.6) 12 (2.8) 6 (7.5) 0.049
Hospital Stay (day) 13.9 ± 7.0 15.3 ± 8.8 13.6 ± 6.5 13.4 ± 6.6 0.048
ICU Stay (day) 7.7 ± 4.2 8.0 ± 4.2 7.5 ± 3.9 8.6 ± 5.7 0.052
Blood loss (ml) 846.0 ± 536.5 792.7 ± 349.3 875.9 ± 617.0 766.8 ± 166.3 0.117
RBC Transfusion Plasma Transfusion PLT Transfusion 4.1 ± 5.0 493.5 ± 538.0 3.0 ± 1.3 4.5 ± 3.1 449.6 ± 382.0 3.1 ± 1.4 4.0 ± 5.4 517.0 ± 585.7 3.0 ± 1.0 3.6 ± 5.6 433.8 ± 463.9 2.9 ± 1.9 0.447 0.27 0.523

TAR+FET, total arch replacement with frozen elephant trunk; ABO, aortic balloon occlusion; HAR, hybrid aortic arch repair; CRRT, continuous renal replacement therapy.